Teva Q3 Revenue Falls 2% to $4.4 Billion, Raises 2026 Brand Outlook
Teva reported third-quarter 2026 revenue of $4.395 billion, down 2% year over year. Gross margin was 55.5%, net income attributable to Teva was $233 million and adjusted diluted EPS was $0.86. The company raised its 2026 revenue outlook for AUSTEDO, AJOVY and UZEDY.
Teva reported third-quarter 2026 revenue of $4.395 billion, down 2% year over year, while gross margin expanded to 55.5%. Net income attributable to Teva was $233 million, and adjusted diluted EPS was $0.86. The company raised its 2026 revenue outlook for AUSTEDO, AJOVY and UZEDY.Financial Highligh…